This is supported by Korja et al., who found that 17 out of 20 NCAM-positive primary neuroblastomas also expressed PSA-NCAM, and those that did express PSA-NCAM were also the most advanced/metastatic tumors at diagnosis (24). This evidence concerns the gene NCAM1 and metastatic neoplasm.